Bausch Health Companies Inc (BHC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,737,600 | 2,015,806 | 986,222 | 612,603 | 254,504 |
| Income taxes - deferred | 81,800 | -515,884 | -319,603 | -249,492 | -55,403 |
| Accounts receivable | -572,400 | -261,380 | -219,431 | -164,581 | 25,187 |
| Accounts payable and accrued liabilities | 188,600 | -76,548 | -29,070 | -8,980 | -76,100 |
| Other Working Capital | -668,400 | -378,291 | -253,278 | -137,119 | -21,864 |
| Other Operating Activity | 1,527,500 | 258,254 | 491,738 | 624,042 | 136,867 |
| Operating Cash Flow | $2,294,700 | $1,041,957 | $656,578 | $676,473 | $263,191 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -291,600 | -115,319 | -107,638 | -58,515 | -1,777 |
| Net Acquisitions | -1,102,600 | -5,253,543 | -3,485,286 | -2,464,108 | 224,450 |
| Purchase Of Investment | -72,000 | 0 | -7,200 | -81,087 | 0 |
| Sale Of Investment | 53,200 | 17,020 | 624,774 | 86,639 | 7,965 |
| Purchase Sale Intangibles | -179,000 | -69,636 | -73,495 | -327,437 | N/A |
| Other Investing Activity | 1,492,300 | 41,092 | 83,124 | 0 | -1,699 |
| Investing Cash Flow | $-99,700 | $-5,380,386 | $-2,965,721 | $-2,844,508 | $228,939 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -9,000 | -47,727 | 4,290 | 0 | 0 |
| Debt Issued | 1,632,600 | 8,441,356 | 6,005,758 | 5,388,799 | 992,400 |
| Debt Repayment | -3,888,000 | -6,326,219 | -2,539,371 | -2,618,112 | -796,381 |
| Common Stock Issued | 0 | 2,307,436 | N/A | N/A | 58,425 |
| Common Stock Repurchased | 0 | -55,629 | -280,724 | -639,242 | -60,130 |
| Dividend Paid | N/A | N/A | 0 | 0 | -356,291 |
| Other Financing Activity | -179,300 | -291,465 | -132,585 | -183,280 | -51,306 |
| Financing Cash Flow | $-2,443,700 | $4,027,752 | $3,057,368 | $1,948,165 | $-213,283 |
| Exchange Rate Effect | -29,000 | -5,074 | 3,755 | -10,288 | 959 |
| Beginning Cash Position | 600,300 | 916,091 | 164,111 | 394,269 | 114,463 |
| End Cash Position | 322,600 | 600,340 | 916,091 | 164,111 | 394,269 |
| Net Cash Flow | $-248,700 | $-310,677 | $748,225 | $-219,870 | $278,847 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,294,700 | 1,041,957 | 656,578 | 676,473 | 263,191 |
| Capital Expenditure | -470,600 | -184,955 | -181,133 | -385,952 | -16,823 |
| Free Cash Flow | 1,824,100 | 857,002 | 475,445 | 290,521 | 246,368 |